During the past decade, Klinikum St. Marien Amberg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum St. Marien Amberg" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "AIO-Studien-gGmbH" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "German CLL Study Group" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum St. Marien Amberg" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "AGO Breast Study Group e.V." with 1 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum St. Marien Amberg" are "Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Adenocarcinoma of the Stomach" (1 trials). Many other conditions were trialed in "Klinikum St. Marien Amberg" in a lesser frequency.

Most popular intervention types in "Klinikum St. Marien Amberg" are "Drug" (22 trials), "Biological" (6 trials), "Radiation" (5 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "radiation therapy" (5 trials), "doxorubicin hydrochloride" (4 trials), "filgrastim" (4 trials) and "prednisone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum St. Marien Amberg" are 17 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum St. Marien Amberg". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Klinikum St. Marien Amberg, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum St. Marien Amberg, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Klinikum St. Marien Amberg has several departments that took part in Clinical trials: "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" - 3 trials